Stocks · News reference
GeneDx To Present New Results At International Consortium On Newborn Sequencing For Its Genomic Newborn Screening
GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced new findings to be presented at the International Consortium on Newborn Sequencing
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
GeneDx Partners With Beren Therapeutics To Launch The NPC GenomeComplete Sponsored Testing Program For Niemann-Pick Disease Type C
The program provides no-cost comprehensive genome sequencing for eligible pediatric patients with clinical findings, family history, or biomarker evidence suggestive of Niemann-Pick Disease Type C (NPC), helping address
Short Sellers Are All-In on These 10 Stocks — Squeeze Watch List Inside
Ondas, SoundHound AI and CleanSpark are in the top ten most-heavily shorted stocks in the market right now.